[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Corneal Graft Rejection pipeline...

April 2021 35 pages

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Developm...

April 2021 80 pages

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Coronaviridae Infections pip...

April 2021 35 pages

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 provides...

April 2021 30 pages

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic...

April 2021 30 pages

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021

 US$ 3,000.00

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021 SUMMARY Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing...

April 2021 35 pages

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021

 US$ 3,000.00

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 SUMMARY CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 provides in depth analysis on CREB Binding P...

April 2021 40 pages

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Creu...

April 2021 35 pages

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021

 US$ 3,000.00

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 SUMMARY Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 prov...

April 2021 30 pages

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cryptococcal Men...

April 2021 35 pages

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Cushing's Syndrome pipel...

April 2021 40 pages

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an overview of the Cutaneous Lupus Eryt...

April 2021 35 pages

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Cutaneous T-Cell Lymphoma pipeli...

April 2021 105 pages

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021

 US$ 3,000.00

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021 SUMMARY Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 D...

April 2021 30 pages

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021

 US$ 3,000.00

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 provides in depth analysis on Cyclin Depen...

April 2021 35 pages

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 202...

April 2021 30 pages

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021

 US$ 3,000.00

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021 S...

April 2021 30 pages

Cystinuria (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Cystinuria (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Cystinuria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Cystinuria pipeline landscape. The report pr...

April 2021 30 pages

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021

 US$ 3,000.00

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021 SUMMARY Cytokine Receptor Common Subunit Gamma (Interleuki...

April 2021 50 pages

Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021 SUMMARY Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021 provides an overview o...

April 2021 65 pages

Cytopenia (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Cytopenia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Cytopenia (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Cytopenia pipeline landscape. The...

April 2021 30 pages

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) - Drugs in Development, 2021

 US$ 3,000.00

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) - Drugs in Development, 2021 SUMMARY Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or...

April 2021 35 pages

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021

 US$ 3,000.00

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 SUMMARY Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associate...

April 2021 140 pages

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021

 US$ 3,000.00

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021 SUMMARY D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021

 US$ 3,000.00

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021 SUMMARY D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 70 pages

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) - Drugs in Development, 2021

 US$ 3,000.00

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) - Drugs in Development, 2021 SUMMARY D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Do...

April 2021 45 pages

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021

 US$ 3,500.00

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 SUMMARY D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 190 pages

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021

 US$ 3,000.00

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021 SUMMARY D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 95 pages

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs in Development, 2021

 US$ 3,000.00

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs in Development, 2021 SUMMARY D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs i...

April 2021 50 pages

Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Dedifferentiated Liposarco...

April 2021 45 pages

Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021 SUMMARY Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021 provides an overview of the Delayed Graft Function...

April 2021 35 pages

Delirium (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Delirium (Central Nervous System) - Drugs in Development, 2021 SUMMARY Delirium (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Delirium pipeline landscape. The repor...

April 2021 30 pages

Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021

 US$ 3,000.00

Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021 SUMMARY Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021 provides in depth analysis on De...

April 2021 105 pages

Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development,...

April 2021 65 pages

Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021 SUMMARY Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Demyelinat...

April 2021 40 pages

Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021 SUMMARY Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021 provides an overview of the Dental Caries pipeli...

April 2021 30 pages

Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021 provides an ov...

April 2021 35 pages

Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021 SUMMARY Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021 provides an overview of the Dermatitis (Eczema) pipeline landscape...

April 2021 55 pages

Dermatological Disorders (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Dermatological Disorders (Dermatology) - Drugs in Development, 2021 SUMMARY Dermatological Disorders (Dermatology) - Drugs in Development, 2021 provides an overview of the Dermatological Disorders pip...

April 2021 70 pages

Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Diabetic Complic...

April 2021 50 pages

Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of...

April 2021 30 pages

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Diab...

April 2021 80 pages

Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 SUMMARY Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Diastolic Heart Failure...

April 2021 65 pages

Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021

 US$ 3,000.00

Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021 SUMMARY Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021 provides in depth analysis on Dihydrofolate...

April 2021 50 pages

Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroorotate Oxidase or DHODH or EC 1.3.5.2) - Drugs in Development, 2021

 US$ 3,000.00

Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroorotate Oxidase or DHODH or EC 1.3.5.2) - Drugs in Development, 2021 SUMMARY Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroo...

April 2021 45 pages

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or...

April 2021 35 pages

DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021

 US$ 3,000.00

DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021 SUMMARY DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021 provides in depth analysis on DNA...

April 2021 35 pages

DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021

 US$ 3,000.00

DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021 SUMMARY DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021 provides i...

April 2021 30 pages

DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021

 US$ 3,000.00

DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021 SUMMARY DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021 provides in depth analysis on DNA Topoisomerase I...

April 2021 105 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1